We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+13.76%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$61.1B
AUM Growth
+$6.8B
(+13%)
Cap. Flow
-$1.88B
Cap. Flow
% of AUM
-3.07%
Top 10 Holdings %
Top 10 Hldgs %
23.3%
Holding
1,241
New
198
Increased
365
Reduced
338
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$348M |
| 2 |
Elanco Animal Health
ELAN
|
+$327M |
| 3 |
Norfolk Southern
NSC
|
+$273M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$258M |
| 5 |
Medtronic
MDT
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$490M |
| 2 |
CHL
China Mobile Limited
CHL
|
+$445M |
| 3 |
Edison International
EIX
|
+$392M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$384M |
| 5 |
RTX Corp
RTX
|
+$366M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.22% |
| 2 | Healthcare | 15.06% |
| 3 | Financials | 13.35% |
| 4 | Industrials | 12.52% |
| 5 | Communication Services | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Pediatrix Medical
MD
$2.17B
| $37.8M | 0.06% |
1,390,670
+835,444
| +150% | +$28M |
|
202
AngioDynamics
ANGO
$610M
| $36.6M | 0.06% |
1,599,848
+1,114
| +0.1% | +$24.2K |
|
203
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $36.5M | 0.06% |
962,565
-5,450
| -0.6% | -$201K |
|
204
Carter's
CRI
$1.39B
| $36.4M | 0.06% |
361,623
+242,155
| +203% | +$21.6M |
|
205
Omnicom Group
OMC
$21.8B
| $36.4M | 0.06% |
498,130
-318,688
| -39% | -$23.9M |
|
|
PSB
206
DELISTED
PS Business Parks, Inc.
PSB
| $36.2M | 0.06% |
231,025
+141,855
| +159% | +$20.7M |
|
|
CBM
207
DELISTED
Cambrex Corporation
CBM
| $35.9M | 0.06% |
924,844
+133,133
| +17% | +$5.45M |
|
208
FTI Consulting
FCN
$4.53B
| $35.5M | 0.06% |
462,320
+372,835
| +417% | +$26.3M |
|
209
BlackRock Resources & Commodities Strategy Trust
BCX
$902M
| $35.5M | 0.06% |
4,341,793
-186,062
| -4% | -$1.47M |
|
210
Elevance Health
ELV
$81.6B
| $35.1M | 0.06% |
122,408
-62,331
| -34% | -$18M |
|
|
GAM
211
General American Investors Company
GAM
$1.55B
| $35.1M | 0.06% |
1,052,774
| – | – |
|
|
CLGX
212
DELISTED
Corelogic, Inc.
CLGX
| $34.8M | 0.06% |
933,485
+135,189
| +17% | +$4.99M |
|
213
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| – | – |
0
| – | – |
|
214
Banco Macro
BMA
$6.02B
| $34.3M | 0.06% |
750,323
-14,528
| -2% | -$747K |
|
215
Marcus Corp
MCS
$912M
| $34.3M | 0.06% |
855,500
+352,110
| +70% | +$14.6M |
|
216
SLB Ltd
SLB
$72.6B
| $34.2M | 0.06% |
785,500
+31,216
| +4% | +$1.35M |
|
217
Eastman Chemical
EMN
$8.01B
| $34M | 0.06% |
447,531
+37,759
| +9% | +$3M |
|
218
SPDR Gold Trust
GLD
$133B
| $33.8M | 0.06% |
276,671
-2,791
| -1% | -$344K |
|
219
AutoZone
AZO
$49.1B
| $33.6M | 0.06% |
32,801
+27,664
| +539% | +$24.8M |
|
220
Americold
COLD
$4.13B
| $33.1M | 0.05% |
1,084,038
+114,678
| +12% | +$3.3M |
|
221
Core Laboratories
CLB
$477M
| $32.7M | 0.05% |
473,880
+86,000
| +22% | +$5.77M |
|
|
NSA
222
DELISTED
National Storage Affiliates Trust
NSA
| $32.6M | 0.05% |
1,144,712
-8,000
| -0.7% | -$222K |
|
|
PXD
223
DELISTED
Pioneer Natural Resource Co.
PXD
| $32.5M | 0.05% |
213,418
+25,139
| +13% | +$3.55M |
|
224
Ingevity
NGVT
$2.44B
| $31.3M | 0.05% |
295,983
-66,930
| -18% | -$6.72M |
|
225
CBRE Group
CBRE
$43.3B
| $31.2M | 0.05% |
630,330
+23,305
| +4% | +$1.09M |
|
Similar funds
QCM
Lazard Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Lazard Asset Management held 1,241 positions worth $61.1B, up 13% from $54.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lazard Asset Management withdrew a net $1.88B in Q1 2019, closing 99 positions and reducing 338 holdings. Its most notable exit was PG&E, an estimated $490M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lazard Asset Management opened a new position in Elanco Animal Health worth $341M.
- Lazard Asset Management's largest Q1 2019 buy was Elanco Animal Health: 10,640,964 shares worth $341M.
- Lazard Asset Management added most to Intercontinental Exchange in Q1 2019, an estimated $348M increase.
- Lazard Asset Management's biggest Q1 2019 reduction was China Mobile Limited, cutting an estimated $445M.
- Lazard Asset Management fully exited PG&E in Q1 2019, selling an estimated $490M.
- Lazard Asset Management's ten largest holdings make up 23% of its $61.1B portfolio in Q1 2019.
- Lazard Asset Management opened 198 new positions and closed 99 in Q1 2019.
- Lazard Asset Management's portfolio value rose 13% quarter-over-quarter to $61.1B.
Based on Lazard Asset Management's 13F filing for Q1 2019, filed 13 May 2019.